Company / Operating Margin
Aurinia Pharmaceuticals Inc. Operating Margin History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
37.1%
FY2025
5-year range
-28598.4% / 37.1%
FY2021-FY2025
Trend
+1962.3%
vs FY2024
Sector context
#12 of 135
Health Care
What the data says
Operating Margin changed +1962% YoY in FY2025, a notable deviation from the 5-year average annual change of -2282%.
Based on SEC 10-K filings.
37.1% in FY2025 with a 5-year CAGR of +245.2%. Top quartile in the Health Care sector.
Improved from -52.2% to 37.1% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +245.2pp
- 5-Year Change
- +245.2pp
- 10-Year Change
- -
Sector benchmark
Top 9% in Health CareTop 9% of 135This company 37.1% Sector average -774.4%
▼
+104.8% above sector average
Key checks
Key Insights
- Aurinia Pharmaceuticals Inc.'s operating margin has grown for 4 consecutive years.
- In FY2025, operating margin increased 1962.3% year-over-year.
- Currently 811.5pp above the Health Care sector average.
- Lowest operating margin in the period was in FY2021.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 37.1% | +1962.3% |
| FY2024 | -2.0% | +96.2% |
| FY2023 | -52.2% | +74.9% |
| FY2022 | -208.1% | +99.3% |
| FY2021 | -28598.4% | -13643.3% |
| FY2020 | -208.1% | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026